Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer? by Angela Dalia Ricci, Alessandro Rizzo

Get full text

Challenges and Future Trends of Hepatocellular Carcinoma Immunotherapy by Alessandro Rizzo, Angela Dalia Ricci

Get full text

The DNA damage repair (DDR) pathway in biliary tract cancer (BTC): a new Pandora’s box? by Angela Dalia Ricci, Alessandro Rizzo, Giovanni Brandi

Get full text

Bayesian Analysis Supports Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma by Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi

Get full text

PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer by Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi

Get full text

Trans-Arterial Chemoembolization Plus Systemic Treatments for Hepatocellular Carcinoma: An Update by Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi

Get full text

Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look by Angela Dalia Ricci, Alessandro Rizzo, Giovanni Brandi

Get full text

Ampullary Carcinoma: An Overview of a Rare Entity and Discussion of Current and Future Therapeutic Challenges by Alessandro Rizzo, Vincenzo Dadduzio, Lucia Lombardi, Angela Dalia Ricci, Gennaro Gadaleta-Caldarola

Get full text

Landscape and Future Perspectives of Immunotherapy in Neuroendocrine Neoplasia by Ilaria Maggio, Lisa Manuzzi, Giuseppe Lamberti, Angela Dalia Ricci, Nastassja Tober, Davide Campana

Get full text

Immune-Based Combinations versus Sorafenib as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Meta-Analysis by Alessandro Rizzo, Angela Dalia Ricci, Annarita Fanizzi, Raffaella Massafra, Raffaele De Luca, Giovanni Brandi

Get full text

Dose reduction and discontinuation of standard-dose regorafenib associated with adverse drug events in cancer patients: a systematic review and meta-analysis by Alessandro Rizzo, Margherita Nannini, Marco Novelli, Angela Dalia Ricci, Valerio Di Scioscio, Maria Abbondanza Pantaleo

Get full text

The Use of Phytochemicals to Improve the Efficacy of Immune Checkpoint Inhibitors: Opportunities and Challenges by Deniz Can Guven, Taha Koray Sahin, Alessandro Rizzo, Angela Dalia Ricci, Sercan Aksoy, Kazim Sahin

Get full text

Systemic Treatment for Metastatic Biliary Tract Cancer: State of the Art and a Glimpse to the Future by Alessandro Rizzo, Angela Dalia Ricci, Antonio Cusmai, Silvana Acquafredda, Giuseppe De Palma, Giovanni Brandi, Gennaro Palmiotti

Get full text

Molecular Profile and Prognostic Value of <i>BAP1</i> Mutations in Intrahepatic Cholangiocarcinoma: A Genomic Database Analysis by Alessandro Rizzo, Riccardo Carloni, Angela Dalia Ricci, Alessandro Di Federico, Deniz Can Guven, Suayib Yalcin, Giovanni Brandi

Get full text

The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis by Deniz Can Guven, Taha Koray Sahin, Enes Erul, Alessandro Rizzo, Angela Dalia Ricci, Sercan Aksoy, Suayib Yalcin

Get full text

Novel HER2-Directed Treatments in Advanced Gastric Carcinoma: AnotHER Paradigm Shift? by Angela Dalia Ricci, Alessandro Rizzo, Fabiola Lorena Rojas Llimpe, Francesca Di Fabio, Dario De Biase, Karim Rihawi

Get full text

The Impact of Concomitant Proton Pump Inhibitors on Immunotherapy Efficacy among Patients with Urothelial Carcinoma: A Meta-Analysis by Alessandro Rizzo, Matteo Santoni, Veronica Mollica, Angela Dalia Ricci, Concetta Calabrò, Antonio Cusmai, Gennaro Gadaleta-Caldarola, Gennaro Palmiotti, Francesco Massari

Get full text

Targeting tumor microenvironment for cholangiocarcinoma: Opportunities for precision medicine by Riccardo Carloni, Alessandro Rizzo, Angela Dalia Ricci, Alessandro Di Federico, Raffaele De Luca, Deniz Can Guven, Suayib Yalcin, Giovanni Brandi

Get full text

Is post‐transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases? by Giovanni Brandi, Angela Dalia Ricci, Alessandro Rizzo, Chiara Zanfi, Simona Tavolari, Andrea Palloni, Stefania De Lorenzo, Matteo Ravaioli, Matteo Cescon

Get full text

PARP Inhibitors in Biliary Tract Cancer: A New Kid on the Block? by Angela Dalia Ricci, Alessandro Rizzo, Chiara Bonucci, Nastassja Tober, Andrea Palloni, Veronica Mollica, Ilaria Maggio, Marzia Deserti, Simona Tavolari, Giovanni Brandi

Get full text